First-Line ICI Therapy for Metastatic Melanoma

First-Line ICI Therapy for Metastatic Melanoma

Apply practice-changing data to inform first-line treatment selection decisions for patients with metastatic melanoma Apply practice-changing data to inform treatment-sequencing decisions for patients with metastatic melanoma Implement evidence-based strategies to monitor and mitigate immune-related adverse events to optimize treatment adherence and patient outcomes

  • Provider:Global Learning Collaborative
  • Activity Link: https://reachmd.com/
  • Start Date: 2024-06-24 05:00:00
  • End Date: 2024-06-24 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.